Riverhead Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Riverhead Capital Management's NVO Position: Q4 2018 in Review
Riverhead Capital Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 25,600 shares — an estimated $603K sold.
Riverhead Capital Management first reported a position in NVO in Q2 2013 and held it in 20 quarters. The position peaked at $3.73M in Q4 2015. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.
- Riverhead Capital Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
- Riverhead Capital Management sold 25,600 Novo Nordisk shares in Q4 2018, an estimated $603K.
- Riverhead Capital Management first reported a position in Novo Nordisk in Q2 2013 and held it in 20 quarters.
- Riverhead Capital Management's Novo Nordisk position peaked at $3.73M in Q4 2015.
- 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.
Based on Riverhead Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.